Global Safety Lancets Market Growth 2025-2031

Global Safety Lancets Market Growth 2025-2031

The global Safety Lancets market size is predicted to grow from US$ 636 million in 2025 to US$ 892 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.

Safety lancets are single-use devices for capillary blood sampling dedicated to healthcare professionals. They are an integral component to the sharps-injury prevention programs in hospitals, clinics, laboratories, doctor’s offices and wherever both patients and professionals need to feel safe. By using safety lancets, needle-stick injuries and infections can be eliminated.

Drivers of the Safety Lancets Market:

Increasing Prevalence of Diabetes: The growing incidence of diabetes globally has led to a rise in the demand for frequent blood glucose monitoring. Safety lancets are widely used in diabetes management, driving the market.

Focus on Safety and Infection Control: Concerns over needle-stick injuries and blood borne infections are pushing healthcare providers to adopt safer devices like safety lancets, which minimize these risks through single-use mechanisms.

Rising Home Healthcare Adoption: The trend toward home-based care, especially for patients with chronic conditions, has increased the demand for user-friendly medical devices, including safety lancets.

Technological Innovation: Advancements in lancet design, such as automatic, pain-minimizing, and ergonomically improved lancets, are enhancing patient experience and encouraging wider adoption.

Government Regulations and Support: Many governments have implemented strict regulations that favor the use of safety-engineered devices to improve healthcare worker safety, fostering the growth of the safety lancets market.

Challenges of the Safety Lancets Market:

Higher Costs: Safety lancets tend to be more expensive than traditional lancets, which can limit adoption, especially in low-resource healthcare settings.

Lack of Awareness in Developing Regions: Limited awareness of safety lancets, along with insufficient healthcare infrastructure in developing countries, hampers market penetration.

Environmental Impact: The single-use nature of safety lancets contributes to medical waste, raising concerns about environmental sustainability and prompting the search for more eco-friendly solutions.

Competition from Alternative Technologies: Emerging blood sampling technologies, such as continuous glucose monitoring (CGM) systems that reduce the need for finger pricking, may present competition to safety lancets.

Limited Reimbursement Policies: In some regions, the lack of favorable reimbursement policies for diagnostic devices like safety lancets can act as a barrier to widespread adoption.

Global key players of safety lancets include HTL-STREFA, BD, Roche, etc. The top three players hold a share about 33%. Americas is the largest market, has a share about 42%, followed by Europe and Asia-Pacific, with share 31% and 23%, separately.

LP Information, Inc. (LPI) ' newest research report, the “Safety Lancets Industry Forecast” looks at past sales and reviews total world Safety Lancets sales in 2024, providing a comprehensive analysis by region and market sector of projected Safety Lancets sales for 2025 through 2031. With Safety Lancets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Safety Lancets industry.

This Insight Report provides a comprehensive analysis of the global Safety Lancets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Safety Lancets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Safety Lancets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Safety Lancets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Safety Lancets.

This report presents a comprehensive overview, market shares, and growth opportunities of Safety Lancets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Safety Lancets with Needle
Safety Lancets with Blade

Segmentation by Application:
Hospital & Clinics
Home
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche
BD
Ascensia
Lifescan
B. Braun
Terumo
Nipro
Cardinal Health
ARKRAY
ICU Medical
Owen Mumford
HemoCue
Greiner Bio One
HTL-STREFA
Sarstedt
UltiMed
Tianjin Huahong
Guangzhou iCare Medical
Shandong Lianfa
SteriLance Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Safety Lancets market?

What factors are driving Safety Lancets market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Safety Lancets market opportunities vary by end market size?

How does Safety Lancets break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.